LBRX
Lb Pharmaceuticals IncCompany with tickers: LBRX
CIK
1691082
CUSIP
50180M108
Shares Outstanding
28,676,652
13F Activity (30d)
71 filings
71 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $22,104,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | $14,645,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | — | ||||
| Net Income | $-19,054,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.67 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.67 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |